Grifols SA (GRFS)
9.205
-0.02
(-0.16%)
USD |
NASDAQ |
Feb 11, 16:00
9.205
0.00 (0.00%)
After-Hours: 16:16
Grifols Total Liabilities (Quarterly) : 14.46B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Akari Therapeutics Plc | 22.69M |
| Pharma Mar SA | 164.26M |
| Autolus Therapeutics Plc | 396.50M |
| Oryzon Genomics SA | 34.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.33B |
| Shareholders Equity (Quarterly) | 6.085B |
| Debt to Equity Ratio | 1.871 |
| Current Ratio | 2.482 |
| Net Debt Paydown Yield | 0.06% |